|

Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and Bronchial Asthma

RECRUITINGN/ASponsored by Charles University, Czech Republic
Actively Recruiting
PhaseN/A
SponsorCharles University, Czech Republic
Started2025-06-03
Est. completion2026-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07183657

Summary

Comprehensive assessment and interventions to promote adherence to inhaled therapy in patients with bronchial asthma and chronic obstructive pulmonary disease involving health care professionals caring for these patients in different settings and using the Five Steps Assessment tool and artificial intelligence methods and tools.

Eligibility

Age: 18 Years+Healthy volunteers accepted
PATIENTS

Inclusion Criteria:

1. signed informed consent,
2. age ≥ 18 years,
3. previously diagnosed BA/COPD meeting GOLD 2024 and GINA 2024 diagnostic criteria,
4. ability to cooperate,
5. at least 8 weeks without exacerbation,
6. use of a particular inhaler for at least 3 months.

Exclusion Criteria:

1. pre-terminal/terminal stage of any disease,
2. uncooperative patient,
3. significant limitation of mobility or cognitive functions.

HEALTHCARE PROFESSIONALS

Inclusion Criteria:

1. signed informed consent,
2. completed education in medicine, pharmacy, or nursing,
3. more than one year of working experience,
4. care for patients taking inhaled therapy for BA/COPD.

Conditions4

AsthmaBronchial AsthmaCOPDChronic Obstructive Pulmonary Disease (COPD)

Browse More Trials

COPD trialsAsthma trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.